Abstract systemic lupus erythematosus (sle) is a disease of unclear causes, which leads to
major immunological disorders. it is characterized by an abnormal immune system activity …

Systemic lupus erythematosus (SLE) is characterized by abnormal action of the immune
system and a state of chronic inflammation. The disease can cause life-threatening …

Advanced glycation end-products (AGEs) may play a relevant role as inducers in the chronic
inflammatory pathway present in immune-mediated diseases, such as systemic lupus …

It has been postulated that advanced glycation end products (AGEs) and their soluble
receptor (sRAGE) may play a relevant role as inducers in the chronic inflammatory pathway …

In recent years, the role of high mobility group box‐1 (HMGB1) protein and its receptors in
autoimmune diseases has received increasing attention. It has been documented that …

Incubation of proteins with glucose lead to their non-enzymatic glycation ultimately resulting
in the formation of advanced glycation end products (AGEs) in vivo. AGEs alter unique three …

ABSTRACT Systemic Lupus Erythematosus (SLE), a systemic autoimmunedisease has an
increased risk for diabetes mellitus (DM) due to accelerated atherosclerosis. The …

Systemic lupus erythematosus (SLE) is an archetype of systemic autoimmune disease,
characterized by the presence of diverse autoantibodies and chronic inflammation. There …

Systemic lupus erythematosus (SLE) is an autoimmune disease, which is highly
inflammatory. Compared to a healthy control group, SLE patients exhibit a higher …

A Soluble Receptor for Advanced Glycation End Product Levels in Patients with Systemic
Lupus Erythematosus Page 1 doi: 10.5606/tjr.2013.2845 Turk J Rheumatol 2013;28(2):101-108 …